Showing results (1-10 of 24) with videos related to
Sort By:
Pageof 3
Current Opinion in Immunology|May 12, 2004
Apoptosis and loss of virus-specific CD8+ T-cell memoryRaymond M Welsh, Kapil Bahl, Xiaoting Z WangJournal of Virology|March 5, 2010
Analysis of apoptosis of memory T cells and dendritic cells during the early stages of viral infection or exposure to toll-like receptor agonistsKapil Bahl, Anette Hüebner, Roger J Davis, et al.The Journal of Experimental Medicine|September 6, 2007
Programmed death-1 (PD-1) defines a transient and dysfunctional oligoclonal T cell population in acute homeostatic proliferationSue-Jane Lin, Craig D Peacock, Kapil Bahl, et al.Molecular Therapy. Nucleic Acids|January 1, 2024
mRNA vaccine trafficking and resulting protein expression after intramuscular administrationKimberly J Hassett, Ivana Liric Rajlic, Kapil Bahl, et al.Proceedings of the National Academy of Sciences of the United States of America|November 12, 2014
In vitro evolution of high-titer, virus-like vesicles containing a single structural proteinNina F Rose, Linda Buonocore, John B Schell, et al.Journal of Immunology (Baltimore, Md. : 1950)|March 21, 2006
IFN-induced attrition of CD8 T cells in the presence or absence of cognate antigen during the early stages of viral infectionsKapil Bahl, Sung-Kwon Kim, Claudia Calcagno, et al.Virology|January 16, 2015
Antigenic requirement for Gag in a vaccine that protects against high-dose mucosal challenge with simian immunodeficiency virusJohn B Schell, Kapil Bahl, Ewa Folta-Stogniew, et al.Vaccines|July 10, 2020
Tetravalent Immunogen Assembled from Conserved Regions of HIV-1 and Delivered as mRNA Demonstrates Potent Preclinical T-Cell Immunogenicity and BreadthNathifa Moyo, Edmund G Wee, Bette Korber, et al.Vaccine|April 28, 2012
Viral vectored granulocyte-macrophage colony stimulating factor inhibits vaccine protection in an SIV challenge model: protection correlates with neutralizing antibodyJohn B Schell, Kapil Bahl, Nina F Rose, et al.Frontiers in Immunology|July 12, 2019
A Modified mRNA Vaccine Targeting Immunodominant NS Epitopes Protects Against Dengue Virus Infection in HLA Class I Transgenic MiceClaude Roth, Tineke Cantaert, Chloé Colas, et al.Pageof 3